Publications by authors named "Bryan Diaz"

Claim this Profile
P
Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals.
Wen Du, Junqiang Wang, Taiyi Kuo, Liheng Wang, Wendy M McKimpson, Bryan S Diaz

J Clin Invest· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-agent FOXO1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice.
Yun-Kyoung Lee, Wen Du, Yaohui Nie, Bryan Diaz, Nishat Sultana

Mol Metab· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes.
Takumi Kitamoto, Yun-Kyoung Lee, Nishat Sultana, Hitoshi Watanabe, Wendy M McKimpson, Bryan Diaz

Mol Metab· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice.
Yun-Kyoung Lee, Bryan Diaz, Marianne Deroose, Samuel X Lee, Sandro Belvedere

Mol Metab· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Arm, Open-Label Phase 2 Trial of Preemptive Methylprednisolone to Avert Progression to Respiratory Failure in High-Risk Patients with COVID-19.
Fernando Cabanillas, Javier Morales, José G Conde, Jorge Bertrán-Pasarell, Ricardo Fernández

medRxiv· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-derived neurotrophic factor signaling mitigates the impact of acute social stress.
Anna M Rosenhauer, Linda Q Beach, Elizabeth C Jeffress, Brittany M Thompson, Katharine E McCann, Bryan Diaz

Neuropharmacology· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis